Abstract
Microsatellite instability is an important characteristic of many tumor types1–8 especially those associated with hereditary non–polyposis colorectal carcinoma (HNPCC) syndrome6–8. Microsatellite alterations in 50% of primary small cell lung carcinoma (SCLC) have been found. These alterations were also found in the sputum4. Because neoplastic characteristics such as decreased strand stability9 and ras mutations10–12 have been found in the plasma DNA of cancer patients, we looked for microsatellite alterations in the plasma of SCLC patients. A microsatellite alteration was present in 16 out of 21 (76%) SCLC tumors and in 15 out of 21 (71%) plasma samples. In one case, the alteration was present only in the plasma DNA. If confirmed in larger studies, microsatellite analysis of plasma DNA might constitute a new tool for tumor staging, management and, possibly, detection.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Vogelstein, B. et al. Allelotype of colorectal carcinomas. Science 244, 207–211 (1989).
Thibodeau, S.N., Bren, G. & Schaid, D. Microsatellite instability in cancer of the proximal colon. Science 260, 816–819 (1993).
Merlo, A. et al. Frequent microsatellite instability in primary small cell lung cancer. Cancer Res. 34, 2098–2101 (1994).
Mao, L. et al.. . Microsatellite alterations as clonal markers for the detection of human cancer. Proc. Natl. Acad. Sci. USA 91, 9871–9875 (1994).
Mao, L. et al.. Molecular detection of primary bladder cancer by microsatellite analysis. Science 271, 659–662 (1996).
Peltomaki, P. et al.. Microsatellite instability is associated with tumors that characterize the hereditary non-polyposis colorectal carcinoma syndrome. Cancer Res. 53, 5853–5855 (1993).
Lynch, H.T. et al. Genetics, natural history, tumor spectrum and pathology of HNPCC an updated review. Gastroenterology 104, 1535–1549 (1993).
Kolodner, R.D. et al.. Structure of the human MLH1 locus and analysis of a large hereditary nonpolyposis colorectal carcinoma kindred for mlhl mutations. Cancer Res. 55, 242–248 (1995).
Stroun, M. et al.. Neoplastic characteristics of the DNA found in the plasma of cancer patients. Oncology 46, 318–322 (1989).
Vasyukhin, V. et al.. K-ras point mutations in the blood plasma DNA of patients with colorectal tumors, in Challenges of Modern Medicine: Biotechnology Today. (eds. Verna, R. & Shamoo, A.) 141–150 (Ares-Serono Symposia Publications, Rome, 1994).
Vasyukhin, V. et al.. Point mutations of the N-ras in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia. Br.H.Haematol. 86, 774–779 (1994).
Sorenson, G.D. et al.. Soluble normal and mutated DNA sequences from single-copy genes in human blood. Cancer Epidemiol Biomark. Prev. 3, 67–71 (1994)
Nagel, S. et al.. Somatic mutations detected by mini- and microsatellite DNA markers reveal clonal intratumor heterogeneity in gastrointestinal cancers. Cancer Res. 55, 2866–2870 (1995).
Nawroz, H., Koch, W., Anker, P., Stroun, M. & Sidransky, D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nature Med. 2, 1036–1038 (1996).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Qi Chen, X., Stroun, M., Magnenat, JL. et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2, 1033–1035 (1996). https://doi.org/10.1038/nm0996-1033
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/nm0996-1033
This article is cited by
-
Enhanced cancer detection from cell-free DNA
Nature Biotechnology (2022)
-
Stance of MRD in Non-Hodgkin’s Lymphoma and its upsurge in the novel era of cell-free DNA
Clinical and Translational Oncology (2021)
-
The interplay of circulating tumor DNA and chromatin modification, therapeutic resistance, and metastasis
Molecular Cancer (2019)
-
A view on drug resistance in cancer
Nature (2019)
-
Progress toward liquid biopsies in pediatric solid tumors
Cancer and Metastasis Reviews (2019)